ArticleAdvances in therapy2018

Subcutaneous Interferon-β1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing Surveillance.

Meritxell Sabidó et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.